Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-14
2010-10-12
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S338000
Reexamination Certificate
active
07812024
ABSTRACT:
The present invention provides modulators of serotonin receptors, pharmaceutical compositions containing such modulators and methods for treating various diseases, conditions and disorders associated with modulation of serotonin receptors such as, for example: metabolic diseases, which includes but is not limited to obesity, diabetes, diabetic complications, atherosclerosis, impaired glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder, sexual disorder and social phobias; cephalic pain; migraine; and gastrointestinal disorders using such compounds and compositions.
REFERENCES:
patent: 3517012 (1970-06-01), Regnier et al.
patent: 4273773 (1981-06-01), Demerson et al.
patent: 5028607 (1991-07-01), Lavielle et al.
patent: 5929085 (1999-07-01), MacDonald et al.
patent: WO 99/42456 (1999-08-01), None
patent: WO 02/059127 (2002-08-01), None
patent: WO 03/076440 (2003-09-01), None
Singh et al., Indian Journal of Chemistry: Section B: Organic Chemistry including Medicinal Chemistry, 1977, 15(1), 70-72.
Database Caplus ′Online! Chemical Abstracts Service, Columbus, Ohio, US; May 12, 1984, XP002316369, retrieved from STN, Database Accession No. 1973:537088 abstract.
Database Caplus ′Online! Chemical Abstracts Service, Columbus, Ohio, US; Jul. 27, 1985, XP002316399, retrieved from STN, Database Accession No. 1985:422553 abstrac.
Database Caplus ′Online! Chemical Abstracts Service, Columbus, Ohio, US; May 12, 1984, XP002316400, retrieved from STN, Database Accession No. 1975:531546 abstract.
Database Caplus ′Online! Chemical Abstracts Service, Columbus, Ohio, US; May 12, 1984, XP002316401, retrieved from STN, Database Accession No. 1977:468283 abstract.
Ferland, J. -M. et al., “Synthesis of derivatives of isoindole and of pyrazino[2,1-a]isoindole”, Can. J. Chem., vol. 63, pp. 361-365 (1985).
Kato, H. et al., “Studies on 1-Azabicyclo Compounds. XV. Oxidation of 1,3,4,6,11,11a-Hexahydro-2H-pyrazino[1,2-b]isoquinolin-1-one Derivatives with Mercuric Acetate, and Their Conversion into 1,2,3,4,5,6,7,8-Octahydro-2-methyl-2,5-benzodiazecine and Related Compounds”, Chem. Pharm. Bull., vol. 21, No. 9, pp. 2039-2047 (1973).
Rao, J. et al., “Synthesis of N-[3-Aryl(thio/sulphono)propyl]heterocyclics as Potential CNS/CVS Agents”, Indian Journal of Chemistry, vol. 26B, pp. 761-765 (1987).
Saxena, A.K. et al., “Compounds Acting on the CNS: Part XXI—Synthesis of 2-Substituted 1,3,4,6,11,11a-Hexahydro-2(H)pyrazino[1,2-b]isoquinoline & Corresponding 8,9-Dimethoxy- & 6-Phenyl-8,9-dimethoxy Analogs”, Indian Journal of Chemistry, vol. 13, pp. 230-237 (1975).
Saxena, M. et al., “Synthesis, Biological Evaluation, and Quantitative Structure-Activity Relationship Analysis of [β-(Aroylamino)ethyl]piperazines and -piperidines and [2-[(Arylamino)carbonyl]ethyl]piperazines, -piperidines, -pyrazinopyridoindoles, and -pyrazinoisoquinolines. A New Class of Potent H1Antagonists”, J. Med. Chem., vol. 33, No. 11, pp. 2970-2976 (1990).
Singh, H. et al., “Studies in Potential Filaricides: Part X—Synthesis of 2-Substituted 1,3,4,6,11,11a-Hexahydro-2H-pyrazino[1,2-b]isoquinolin-6-ones”, Indian Journal of Chemistry, vol. 15B, pp. 70-72 (1977).
Sullivan, H.B. et al., “Synthesis of 1,3,4,6,11,11a-Hexahydro-2H-pyrazino[1,2-b]isoquinoline and Perhydro-1H-pyrazino[1,2-a]quinoline”, Journal of Organic Chemistry, vol. 29, pp. 326-328 (1964).
Welch, W.M., “Synthesis of the 1,2,3,4-Tetrahydropyrazino[2,1-a]isoindol-6(2H)-one Ring System”, J. Org. Chem., vol. 47, No. 5, pp. 886-888 (1982).
Kwon Chet
Stein Philip D.
Zhao Guohua
Bogie Terence J.
Bristol--Myers Squibb Company
Gibbons Maureen S.
Jarrell Noble
Wilson James O
LandOfFree
Modulators of serotonin receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of serotonin receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of serotonin receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4170177